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Summary
Volatile anesthetics (VAs) cause profound neurological
effects, including reversible loss of consciousness and
immobility. Despite their widespread use, the mechanism
of action of VAs remains one of the unsolved puzzles of
neuroscience [1, 2]. Genetic studies in Caenorhabditis
elegans [3, 4], Drosophila [3, 5], and mice [6–9] indicate
that ion channels controlling the neuronal restingmembrane
potential (RMP) also control anesthetic sensitivity. Leak
channels selective for K+ [10–13] or permeable to Na+ [14]
are critical for establishing RMP. We hypothesized that halo-
thane, a VA, caused immobility by altering the neuronal
RMP. In C. elegans, halothane-induced immobility is acutely
and completely reversed by channelrhodopsin-2 based
depolarization of the RMP when expressed specifically in
cholinergic neurons. Furthermore, hyperpolarizing cholin-
ergic neurons via halorhodopsin activation increases sensi-
tivity to halothane. The sensitivity of C. elegans to halothane
can be altered by 25-fold by either manipulation of
membrane conductancewith optogeneticmethods or gener-
ation of mutations in leak channels that set the RMP. Immo-
bility induced by another VA, isoflurane, is not affected by
these treatments, thereby excluding the possibility of
nonspecific hyperactivity. The sum of our data indicates
that leak channels and the RMP are important determinants
of halothane-induced general anesthesia.
Results and Discussion
In C. elegans, unc-79, unc-80, and nca-2;nca-1 mutants each
lack the worm orthologs of mammalian NALCN (sodium leak
channel, nonspecific) and display hypersensitivity to halo-
thane but normal sensitivity to isoflurane [3, 4]. In air, unc-79,
unc-80, and the nca-2;nca-1 mutants are ‘‘fainters’’ (i.e., they
move normally for a few body lengths and then halt). These
mutants also cease movement within 1 s of entering liquid
medium [15]. We refer to the loss-of-function mutations of*Correspondence: pgm4@uw.eduthese genes collectively as nca(lf). Their gene products are
expressed exclusively in neurons [16, 17]. Mammalian NALCN,
known to control the resting membrane potential (RMP) in
mouse neurons [14], rescues the nca-2;nca-1 double mutant
(the two paralogs of NALCN) in C. elegans [16]. Remarkably,
the anesthetic sensitivity and movement phenotypes of nca(lf)
are conserved inDrosophila [3, 5]. The knockout of the NALCN
channel in mice results in a hyperpolarized RMP in hippo-
campal neurons and neonatal death due to abnormal periodic
breathing [14]. We also found that changes in mitochondrial
complex I activity (such as in the mutant gas-1) increase sensi-
tivity to volatile anesthetics (VAs) [18–20]. The present work
attempted to join these two lines of work by identifying
common features between the two groups of mutants.Gene Expression in Halothane-Sensitive
Mitochondrial Mutants
Ion channel pathway expression analysis was performed on
complex I mutants in data sets previously generated (acces-
sion no. GSE9967) [21] using Gene Set Enrichment Analysis
(GSEA). We studied three VA hypersensitive complex I
mutants, gas-1(fc21), F22D6.4 (RNA interference [RNAi]), and
C34B2.8 (RNAi) (EC50s 1.1%, 1.8%, and 2.0%, respectively),
relative to three nonsensitive complex I mutants (RNAi)
(Y45G12B.1, Y56A3A.19, and D2030.4; EC50s 2.9%, 2.9%,
and 3.0%, respectively) and wild-type (N2; EC50 of 3.2%)
animals [19, 20]. Of ion channel gene cluster families analyzed,
only the potassium channel superfamily showed significant
upregulation in the anesthetic sensitive animals (p = 0.00; q =
0.00). Multiple nonion channel pathways were also altered
and will be presented elsewhere. Gene level analysis revealed
that the K2P leak channel subclass of this superfamily was
most highly upregulated in the hypersensitive mutants (see
Supplemental Information and Table S1 available online). Vali-
dation microarray analysis in an independent data set limited
to gas-1(fc21) versus wild-type controls (accession no.
GSE9967) [21] similarly showed upregulation by analysis of
variance (ANOVA) analysis of gene expression for many potas-
sium channel familymembers (data not shown). This upregula-
tion of K2P channels may contribute to the hypersensitivity to
VAs in mitochondrial mutants, as VAs can activate K2P chan-
nels [22] and hyperpolarize the RMP.The Effects of a Potassium Channel Agonist
If hyperpolarizaton of the RMP by activation of a K2P leak
channel mediates anesthetic response, a K2P channel agonist
might be additive with VAs. We tested the effects of a potas-
sium channel agonist, riluzole, on wild-type and mitochondrial
mutants [23] (Figure S1). gas-1 (anesthetic hypersensitive) had
an increased sensitivity to riluzole (Figure S1A), whereas
mev-1 (normal anesthetic sensitivity) [24] had normal sensi-
tivity (Figure S1A). When wild-type (N2) animals were exposed
to 200 mM riluzole, sensitivity to halothane was increased
(3.2% versus 1.9%) (Figure S1B). 200 mM riluzole also
increased the sensitivity of gas-1 to halothane (0.9% versus
0.3%) (Figure S1B). Since riluzole is also known to inhibit
voltage-gated Na+ channels and glutamate release [25], the
Figure 1. K2P Channels Alter Anesthetic Sensitivity in C. elegans
(A) K2P(lfsup-9(n180)) shows a moderate resistance to halothane [N2, EC50 = 3.08% 6 0.06%, K2P(lf), EC50 = 3.35% 6 0.07%, p < 0.006].
(B) K2P(gfunc-92(n200)) shows an increased sensitivity to halothane (EC50 = 1.43% 6 0.07%, p < 0.0001 versus N2).
(C) Loss of function of K2P channels partially rescues anesthetic sensitivity seen in the nca(lf)mutants [nca(lf) EC50 = 0.68%6 0.05%, K2P(lf);nca(lf) EC50 =
0.98% 6 0.05%, p = 0.0002].
(D) Animals carrying bothK2P(gf) and nca(lf) are extremely hypersensitive to halothane [EC50 = 0.18%6 0.03%, versus nca(lf), p < 0.0001 and versusK2P(gf),
p < 0.0001].
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K2P channels.
K2P Channels and Anesthetic Sensitivity
Wepredicted thatmutants lacking K2P channels and therefore
lacking a hyperpolarizing K+ leak current would be resistant to
VAs as seen in mice [6, 7, 9, 26, 27]. C. elegans possesses
approximately 50 genes predicted to encode K2P channels
[28]. One of these, sup-9, is the worm homolog that is most
closely related to the mouse and human K2P channels
TREK-1 (32% identity, clustalw alignment), TASK-1 (55% iden-
tity), and TASK-3 (58% identity). sup-9(n180), a loss-of-func-
tion allele, has no phenotype in air [29] but is 8.7% resistant
to halothane (Figure 1A).
UNC-93 is conserved in humans and thought to regulate the
function of the K+ channel formed by SUP-9 and SUP-10 [29–
32]. We examined the anesthetic sensitivity of the gain-of-
function (gf) alleles of sup-10 and unc-93 [collectively denoted
as K2P(gf)]. K2P(gf) mutants are thought to conduct an
increased K+ current out of the cell [29]. The weakest of these
gf alleles, unc-93 (n200), is extremely sensitive to halothane
with an EC50 of 1.43% 6 0.07% (Figure 1B). Other K2P(gf)
mutants such as sup-10(n983) are also very hypersensitive to
halothane (Figure S2, EC50 = 1.21%6 0.007%). Similar results
were seen with isoflurane (data not shown). The anesthetichypersensitivity of unc-93(gf) and sup-10(gf) mutants can be
suppressed by the sup-9(lf) alleles n180 and n1550n2174 [Fig-
ure S2, sup-9(n180);unc-93(n200) EC50 = 3.56%6 0.17%, sup-
9(n1550n2174);sup-10(n983) EC50 = 3.74% 6 0.06%]. These
results suggest that K2P channel function is integral to anes-
thetic action in C. elegans.
We next examined how theK2P gf or lf alleles interactedwith
the loss of function of the NCA channels. The K2P(lf)mutation
sup-9(n180) increased the EC50 of the nca(lf) mutant
nca-2(gk5);nca-1(gk9) by 44% (Figure 1C). We next combined
a nca(lf) mutation, unc-80(e1272), with a K2P(gf) mutation,
unc-93(n200) (Figure 1D). These double mutants move
well in air but show a striking 17-fold reduction from the
wild-type EC50 in halothane (0.18% 6 0.02% versus 3.1% 6
0.05%).
Optogenetic Reversal of Anesthesia
Cholinergic Neurons
If hyperpolarization of neurons in nca(lf) and K2P(gf) mutants
causes the movement defects and halothane hypersensitivity,
a depolarizing cationic current should rescue the defects.
Channelrhodopsin-2 (ChR2) is a retinal dependent blue-light-
activated cation channel from Chlamydomonas reinhardtii
that has been used extensively in C. elegans to depolarize
both muscle and neurons [33–35]. We expressed ChR2 in
Figure 2. Rescue of nca(lf) and K2P(gf) Movement Defects
Swimming is moderately and severely impaired in K2P(gf) and nca(lf)mutants respectively, as measured by the number of thrashes/sec. Activation of chan-
nelrhodopsin-2 (ChR2) significantly improves swimming in retinal fed nca(lf);Punc-17::ChR2 compared to the same worms before ChR2 activation by blue
light and when compared to blue-light-exposed non-retinal fed nca(lf);Punc-17::ChR2 or nca(lf). Upon cessation of blue light stimulation, these worms
became paralyzed again. Activation of ChR2 in retinal fed K2P(gf);Punc-17::ChR2 worms lead to more thrashes compared to the non-retinal fed and
non-blue-light-exposed controls. All bars represent the mean values of at least six measurements and are represented in the figure. Error bars represent
SEM.
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nca(lf) and K2P(gf) backgrounds.
nca(lf);Punc-17::ChR2 animals, like nca(lf) animals [17], were
not able to swim in liquid medium (N2 = 1.25 6 0.04 thrashes/
sec, nca(lf) = 0.096 0.28 thrashes/sec, nca(lf);Punc-17::ChR2,
no retinal = 0.05 6 0.005 thrashes/sec, Figure 2). When
blue light was used to activate ChR2 in the retinal fed
nca(lf);Punc-17::ChR2 animals, they were able to swim nor-
mally (Movie S1; Figure 2, nca(lf);Punc-17::ChR2 retinal fed
[during blue light] = 0.85 6 0.02 thrashes/sec). The fainting
movement was also rescued upon ChR2 activation by blue
light (Movie S2). K2P(gf) mutants, although not as severely
impaired as the nca(lf) mutants, were inhibited relative to N2
worms and improved upon ChR2 activation (K2P(gf);Punc-
17::ChR2 animals [Figure 2]).
We next examined the anesthetic behavior of N2 animals ex-
pressing ChR2 under Punc-17. We activated ChR2 in all
cholinergic neurons in Punc-17::ChR2 animals anesthetized
with halothane (Figure 3A, frames 1–3; Movie S3). Upon activa-
tion, the immobilized worms resumed sinuous motion (Fig-
ure 3A, frames 4–8; Movie S3) and promptly became immobile
upon cessation of blue light illumination (Figure 3A, frames
9–12; Movie S3). Control worms not exposed to blue light
remained immobile, as did control worms exposed to blue light
but not fed retinal (Figure 3B; Movie S4).
The EC50 for the Punc17::ChR2 transgenic worms was
4.3% 6 0.05% with retinal and blue light compared to
3.62% 6 0.04% without retinal and blue light (Figure 3B). The
Punc17::ChR2 strain was resistant to halothane compared towild-type (EC50 3.08% 6 0.06%) before ChR2 activation by
blue light. This may be due to an underlying conductance of
a small leak current when ChR2 is not activated by light and
without the presence of retinal. We also examined whether
immobility due to other anesthetics is reversed by ChR2 acti-
vation. Surprisingly, isoflurane-induced immobility was not
rescued by ChR2 activation (Figure 3C) indicating these two
anesthetics do not have identical mechanisms of action.
Activation of all cholinergic neurons could conceivably
result in generalized animal hyperactivity that results in
a reversal of immobility. Two points argue against this inter-
pretation. First, activation of ChR2 in cholinergic neurons of
nonanesthetized worms did not increase movement but rather
causedworms to become lessmobile (Movie S7). Second, iso-
flurane-induced immobility was not rescued by depolarization
of cholinergic neurons (Figure 3C). Activation of all cholinergic
neurons may overwhelm the effects of anesthetics down-
stream of the neurons and reverse immobility. Therefore, we
anesthetized Pmyo-3::ChR2 animals, which express ChR2
primarily in body wall muscle. These worms responded to
blue light by contracting their muscles, but did not resume
sinuous motion like the Punc-17::ChR2 worms (Figure 3D;
Movie S5). These data together argue against the possibility
that the reversal of immobility by ChR2-based depolarization
is a nonspecific effect of a generalized increase in the excit-
ability of the nervous system. However, it is important to
remember that there are considerable differences in the
expression patterns of nca genes (pan-neuronal) [3, 16, 17],
K2P channels (muscle, interneurons [29], and motorneurons
Figure 3. Reversal of Immobility in C. elegans Expressing Channelrhodopsin-2 in Cholinergic Neurons
(A) Stills taken every 5 s from a movie of a retinal fed Punc-17::ChR2 C. elegans immobilized by 4.85% halothane responding to blue light. Exposure to blue
light causes the worm to resume sinuous motion again. Also see Movie S3.
(B) Dose-response curve showing anesthetic sensitivity of light-activated Punc-17::ChR2 animals under halothane. EC50 is shifted to 4.29%6 0.03% under
blue light for retinal fed worms from 3.62% 6 0.04% for non-retinal fed control worms, p < 0.0001.
(C) Dose-response curve for the Punc-17::ChR2 animals under isoflurane (EC50 retinal fed, blue light 6.4%6 0.45% versus EC50 non-retinal fed, no blue light
6.82% 6 0.1%, p = 0.3603, not significant).
(D) Pmyo-3::ChR2 worms fed with retinal when anesthetized under 4.8% halothane only contract their body wall muscles during blue light stimulation,
resulting in no net movement.
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ascribe all halothane effects only to cholinergic neurons.
Our model predicts that neurons in both wild-type and
hypersensitive animals are similarly hyperpolarized when
anesthetized by halothane. We hypothesized that the nca(lf)
mutants would not only be rescued by ChR2 activation at
a concentration of halothane where all the nca(lf) mutants are
immobile but also at a concentration where wild-type animals
are immobile. To test this model, we determined whether
anesthetic-induced immobility could be reversed in the nca(lf)
hypersensitive mutants. Depolarization of the cholinergic
neurons shifted the EC50 for halothane of the nca(lf);Punc-
17::ChR2 strain to 3.6%, well above the expected EC50 for
wild-type C. elegans (3.1%), and 6-fold higher than the nca(lf)
EC50 of 0.59% 6 0.05% (Figure 4A). Halothane-induced
immobility was also reversed in K2P(gf);Punc-17::ChR2 and
K2P(gf);nca(lf);Punc-17::ChR2 mutants by ChR2 activation,
at concentrations of halothane well beyond the EC100 levels
for each mutant (Figure 4B).
GABAergic Neurons
As in mammals, gamma-aminobutyric acid (GABA) channels
are the primary inhibitory channels in C. elegans. It has been
suggested that VAs work by potentiating a hyperpolarizingchloride current through the GABAA channel [38, 39]. If this
were the case, preventing GABA release in anesthetized
worms should lead to some recovery of mobility. Expression
of halorhodopsin (NpHR), a retinal-dependent chloride pump
from Natromonas pharonais, can be used to hyperpolarize
cells [33]. When NpHR was used to hyperpolarize all
GABAergic neurons in halothane-anesthetized worms, no
recovery of movement was seen. Even at concentrations of
halothane close to the wild-type EC50, control worms were
more mobile than stimulated Punc-47::NpHR worms (Fig-
ure 4C). Therefore, the GABA channel is likely not a physiolog-
ically relevant target for halothane in C. elegans. However,
there are many cys-loop ligand-gated chloride channels in
C. elegans, and it is possible that other members of the super-
family contribute to anesthetic sensitivity.
Halorhodopsin Stimulation Increases Halothane
Sensitivity
If the hypersensitivity seen in the nca(lf), K2P(gf), and the
nca(lf);K2P(gf) double mutant results from neuronal hyperpo-
larization, then we must be able to mimic this hypersensitivity
by hyperpolarizing neurons via othermechanisms. To this end,
we anesthetized worms expressing halorhodopsin under the
Figure 4. Mechanism of Anesthetic-Induced Immobility
(A) In nca(lf);Punc-17::ChR2 depolarizing cholinergic neurons causes a significant rescue of anesthetic sensitivity (EC50 retinal fed worms 3.79% 6 0.04%,
non-retinal fed and without blue light exposure, EC50 < 1%).
(B) K2P(gf);Punc-17::ChR2 and K2P(gf);nca(lf);Punc-17::ChR2 become mobile upon exposure to blue light in halothane [where the K2P(gf) and
K2P(gf);nca(lf) are immobile]. gas-1 Punc-17::ChR2, and gas-1 Punc-17::ChR2;Pmyo-3::ChR2 mutants did not become mobile when ChR2 was activated
in either cholinergic neurons or cholinergic neurons and muscle.
(C) In halothane anesthetized Punc-47::halorhodopsinworms, hyperpolarization of GABAergic neurons by halorhodopsin activation, did not reverse immo-
bility at any concentration of halothane (at 3.18% halothane, no green light, no retinal = 41.6% immobile, green light, retinal fed = 48.9% immobile).
(D) In Punc-17::halorhodopsin worms, hyperpolarization of cholinergic neurons by halorhodopsin activation reduced the amount of halothane required for
immobilization. Sixty-eight percent of animals were immobile at 1.49%halothane. Less than 7%of the non-retinal fed, and non-green-light-exposed animals
were immobile at the same halothane concentration. A similar pattern is seen at 2.16% and 2.26% halothane.
See also Movie S6. All bars in (B)–(D) represent the mean values of at least 25 measurements. Error bars represent the SEM.
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was activated by green light, these worms did not become
immobile but instead phenocopied the nca(lf)mutants by faint-
ing (Movie S6) and becoming hypersensitive to halothane
(Figure 4D).
Failure to Reverse gas-1 Hypersensitivity
Mutations that impair mitochondrial complex I function also
cause anesthetic hypersensitivity in C. elegans [18, 19, 40].
This hypersensitivity was also seen in humans, because
patients with complex I dysfunction were hypersensitive to
VAs [41]. Mitochondrial mutants such as gas-1 overexpress
K2P channels, which can cause a hyperpolarized RMP, and
account for halothane hypersensitivity. Interestingly, gas-
1(fc21) Punc-17::ChR2 did not resume movement with ChR2
activation (Figure 4B). However, gas-1 is expressed in all cells,
including muscle [42]. Therefore, we examined the sensitivity
of a strain of worms expressing ChR2 in both cholinergic
neurons and muscle (gas-1 Punc-17::chop-2; Pmyo-3::chop-
2). Activation of ChR2 in cholinergic neurons and muscle
also failed to reverse immobility (Figure 4B). This suggeststhat the hypersensitivity to anesthetics in mitochondrial
mutants either requires ChR2 action in other neurons or
involves additional mechanisms.
Conclusion
Artificial hyperpolarization of cholinergic neurons by halorho-
dopsin or depolarization by ChR2 significantly alters sensi-
tivity of C. elegans for halothane-induced immobility. These
results support the hypothesis that hyperpolarization under-
lies halothane’s mechanism of action. The same is not true
for isoflurane anesthesia, because ChR2 activation does not
rescue movement of isoflurane anesthetized C. elegans.
However, nca(lf) mutations are also not sensitive to isoflurane
[3]. This provides further support of the hypothesis that
different VAs function via distinct mechanisms, reminiscent
of the difference in isoflurane and halothane protein binding
shown by Eckenhoff et al. [43]. Our work does not show
that either the K2P or the nca channels are direct targets of
VAs. However, the data narrow the field of likely targets to
those that can change membrane polarization in the presy-
napse, which includes both the K2P and NCA channels.
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C. elegans wild-type N2 (Bristol) and the strains unc-93(n200), sup-
10(n983);sup-9(n1550n2174), sup-10(n983), and sup-9(n180) strains were
obtained from theCaenorhabditis Genetics Center (Minneapolis, MN). Other
strains shared by the Jorgensen laboratory are detailed in the Supplemental
Experimental Procedures. Channelrhodopsin-2::mcherry is abbreviated as
ChR2 in themanuscript. Halorhodopsin::GFP is abbreviated as halorhodop-
sin or NpHR.
Swimming Assay
A single worm was picked into 150 ml of S. Basal and allowed a minute to
acclimatize. The number of thrashes was then counted for 10 s as described
by Pierce-Shimomura et al. [15]. The number of thrashes for 10 s in the pres-
ence of blue light was counted and compared to the number after the blue
light was discontinued. Results in Figure 2 represent themeans of six exper-
iments. Error bars represent SEM.
LED Illumination for ChR2 and NpHR Activation
A mightex LED controller (http://www.mightex.com, SLC-MA02-U)
controlled duration and strength of LED illumination. A Luxeon rebel blue
LED (w470 nm) was used for ChR2 activation with 5 ms pulses at 100 Hz,
at 1,000 mA [300 mA for the nca(lf) experiments]. A Luxeon rebel green
LED (w530 nm) was used for halorhodopsin activation using a constant illu-
mination at 1,000mA. A red LEDwas used to illuminate themicroscope field.
Procedures describing anesthetizing nematodes, RNAi treatment, and
microarray analysis are included in the Supplemental Information.
Supplemental Information
Supplemental Information includes two figures, one table, Supplemental
Experimental Procedures, and seven movies and can be found with this
article online at doi:10.1016/j.cub.2011.10.042.
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